# Phosphodiesterase 4 Gene Variant and Salbutamol Response in Persistent Childhood Asthma

> **NCT03592212** · — · TERMINATED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 99 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Salbutamol

## Key facts

- **NCT ID:** NCT03592212
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2018-11-23
- **Primary completion:** 2019-11-14
- **Final completion:** 2019-11-14
- **Target enrollment:** 99 (ACTUAL)
- **Why stopped:** Number of inclusioNs not reached
- **Last updated:** 2026-05-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03592212

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03592212, "Phosphodiesterase 4 Gene Variant and Salbutamol Response in Persistent Childhood Asthma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03592212. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*